Franklin County Bell Across PA Is On The Move Throughout Franklin County

CHAMBERSBURG, Pa., Oct. 9, 2025 /PRNewswire/ — On September 20, more than 150 locals and visitors watched as Sam Worley, a 103-year-old WWII veteran and former commissioner of Franklin County, joined 16-year-old Laine Hess, 2025 Franklin County Fair Queen, to unveil the Franklin County Bell Across PA. After spending a week at the Franklin County […]

Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept)

EYDENZELT® is approved for the treatment of patients with neovascular (wet) age-related macular degeneration (wAMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME), and diabetic retinopathy (DR) Celltrion plans to enter the U.S. ophthalmology market to meet diverse needs of patients suffering from various eye conditions INCHEON, South Korea, Oct. 9, 2025 […]

RE/MAX HOLDINGS, INC. TO RELEASE THIRD QUARTER 2025 RESULTS ON OCTOBER 30, 2025

DENVER, Oct. 9, 2025 /PRNewswire/ — RE/MAX Holdings, Inc. (NYSE:RMAX), parent company of REMAX, one of the world’s leading franchisors of real estate brokerage services, and Motto Mortgage, the first and only national mortgage brokerage franchise brand in the U.S., will release financial results for the quarter ended September 30, 2025, after market close on Thursday, […]

Amplifi Vascular Announces Successful First-in-Human Study Results, Closes $6.8M Series A, and Receives FDA IDE Approval

Company announces positive first-in-human study results, the close of a $6.9 million Series A financing, and FDA approval of its Investigational Device Exemption.  ST. LOUIS, Oct. 9, 2025 /PRNewswire/ — Amplifi Vascular, developer of the first-of-its-kind Vein Dilation System designed to increase eligibility, improve creation and early maturation of arteriovenous fistulas (AVFs) for hemodialysis, today […]

Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer’s Disease Research

New Blood-Based Assay Delivers Unparalleled Sensitivity and Specificity to enable the next generation of assay development.  FREMONT, Calif., Oct. 9, 2025 /PRNewswire/ — Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced the launch of the NULISAqpcr™ BD-pTau217 Assay— a transformative leap in blood-based quantification of brain-derived phosphorylated […]

Grace Adventures Ministries Announces President Retirement

SILVER LAKE, Mich., Oct. 9, 2025 /PRNewswire/ — Grace Adventures Ministries, a leader equipping students and strengthening families since 1946, announces the retirement of its longtime President, Steve Prudhomme, effective March 31, 2026. After nearly three decades of faithful service, Steve will leave behind a rich legacy of impact, discipleship, and transformed lives. Continue Reading Steve […]